ZELTIA, S.A.
CIF A36000602 Spain Chemical industry Pharmaceutical seen 1235 times Last report June 2015
Employees | 686 (49.90% women) |
Profit | -300K € |
Indebtedness | 207.6% |
Income | 155.8M € |
Earnings per share | 0 € |
Solvency | 148.2% | 3.97% |
Short solvency | 109.8% | 17% |
Working balance on income | 22.79% | 76.78% |
Working balance on assets | 29.4% | 55.33% |
Non current assets coverage | 74.59% | 16.14% |
Fixed assets on long term debt | 116.9% | 7.37% |
Cash on Current Assets | 19% | 17.01% |
Inmovilization | 45.88% | -7.11% |
Cash on Current Liabilities | 26.91% | 34.36% |
Leverage | 41.95% | -7.67% |
Debt Quality | 43.39% | 4.47% |
Financial Expenses Coverage | 106% | -66.49% |
Short term Indebtedness | 117.5% | -14.55% |
Long term Indebtedness | 90.09% | -7.8% |
Financial Expenses on EBIT | 94.35% | 198.4% |
Indebtedness Ratio | 67.49% | -3.82% |
Indebtedness on EBIT | 2.11K% | 201.7% |
Assets Turnover | 69.83% | -6.04% |
Customers Turnover | -273.7% | -32.35% |
Fixed Assets Turnover | 152.2% | 1.16% |
Suppliers Turnover | 122.4% | -18.02% |
Profit on Income/Sales | -0.19% | -102.2% |
Earnings per share | 0 € | -100% |
Funds from Operations | 5.49M € | -70.16% |
EBIT Margin | 4.59% | -66.07% |
Operating Margin | 0.56% | -94.2% |
ROA | -0.13% | -102.1% |
ROE | -0.39% | -101.9% |
Profitability | 2.63% | -67.76% |
Economic Profitability | 3.2% | -68.12% |
Rea Estate Profitability | -77.03% | -15.07% |
Expenses/Profit | 667.3% | 194.4% |
EBIT | -106% | -66.49% |
Staff expenses | 69.54K € | 0.81% |
Financial Expenses on Sales | 4.33% | 1.24% |
Cash Flow per share | 0 | -100% |
Cash Flow on assets | 0.1% | -103.4% |
Cash Flow on income/sales | 0.14% | -103.6% |
Dividends on Cash Flow | 0% | 0% |
Cash Flow Margin Ratio | 4.77% | -67.73% |
Cash Flow on short-term Liabilities | -0.26% | -103.6% |
Cash Flow on long-term Liabilities | -0.34% | -103.3% |
Cash Flow on Debt | -0.23% | -103.6% |
External Financing | 941.4% | 874.9% |